Ars Pharmaceuticals Inc (SPRY)

Dec 08, 2025

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 08, 2025

Dec 05, 2025

How ARS Pharmaceuticals Inc. stock reacts to global recession fearsJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser

Dec 05, 2025

Dec 04, 2025

Why ARS Pharmaceuticals Inc. stock is favored by pension fundsPortfolio Update Report & Safe Capital Investment Plans - Newser

Dec 04, 2025

Dec 04, 2025

ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8.1%Here's What Happened - MarketBeat

Dec 04, 2025

Dec 03, 2025

Is ARS Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Momentum & Short-Term Swing Trade Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Discipline and Rules-Based Execution in SPRY Response - news.stocktradersdaily.com

Dec 02, 2025

Dec 01, 2025

ARS Pharmaceuticals, Inc. $SPRY Shares Bought by Geode Capital Management LLC - MarketBeat

Dec 01, 2025

Dec 01, 2025

How Recent Developments Are Shaping the Story for ARS Pharmaceuticals According to Analysts - Yahoo Finance

Dec 01, 2025

Nov 30, 2025

Steward Partners Investment Advisory LLC Raises Stock Position in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat

Nov 30, 2025

Nov 28, 2025

Franklin Resources Inc. Sells 28,789 Shares of ARS Pharmaceuticals, Inc. $SPRY - MarketBeat

Nov 28, 2025

Nov 27, 2025

Universal Beteiligungs und Servicegesellschaft mbH Takes $1.77 Million Position in ARS Pharmaceuticals, Inc. $SPRY - MarketBeat

Nov 27, 2025

Nov 26, 2025

ARS Pharmaceuticals, Inc. to Participate in Piper Sandler 37th Annual Healthcare Conference - Quiver Quantitative

Nov 26, 2025

Nov 26, 2025

ARS Pharmaceuticals (NASDAQ: SPRY) in fireside chat at Piper Sandler 37th Conference - Stock Titan

Nov 26, 2025

Nov 26, 2025

ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 26, 2025

Nov 23, 2025

ARS Pharmaceuticals (NASDAQ:SPRY) Raised to Hold at Zacks Research - MarketBeat

Nov 23, 2025

Nov 21, 2025

Behavioral Patterns of SPRY and Institutional Flows - news.stocktradersdaily.com

Nov 21, 2025

Nov 21, 2025

Is ARS Pharmaceuticals Inc. stock supported by strong fundamentals2025 Key Highlights & Precise Buy Zone Tips - newser.com

Nov 21, 2025

Nov 21, 2025

How ARS Pharmaceuticals Inc. stock valuations compare to rivalsMarket Risk Summary & Long-Term Capital Growth Ideas - newser.com

Nov 21, 2025

Nov 19, 2025

Will ARS Pharmaceuticals Inc. stock maintain momentum in 2025Earnings Overview Summary & Consistent Growth Stock Picks - newser.com

Nov 19, 2025

Nov 19, 2025

How ARS Pharmaceuticals Inc. stock benefits from strong dollarPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Is ARS Pharmaceuticals Inc. stock supported by innovation pipelineQuarterly Growth Report & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Is ARS Pharmaceuticals Inc. a candidate for recovery play2025 Market Trends & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Can ARS Pharmaceuticals Inc. hit a new high this monthJuly 2025 Summary & Fast Momentum Entry Tips - newser.com

Nov 19, 2025

Nov 19, 2025

ARS Pharmaceuticals Inc. stock outlook for YEARQuarterly Growth Report & High Accuracy Buy Signal Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by ARS Investment Partners LLC - MarketBeat

Nov 19, 2025

Nov 19, 2025

Custom strategy builders for tracking ARS Pharmaceuticals Inc.Gold Moves & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Why ARS Pharmaceuticals Inc. stock is recommended by analysts2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com

Nov 19, 2025

Nov 18, 2025

ARS Pharmaceuticals (NASDAQ:SPRY) Sets New 1-Year Low After Insider Selling - MarketBeat

Nov 18, 2025

Nov 17, 2025

ARS Pharmaceuticals, Inc. (SPRY) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 17, 2025

Nov 17, 2025

ARS Pharmaceuticals Insider Sold Shares Worth $1,476,147, According to a Recent SEC Filing - MarketScreener

Nov 17, 2025

Nov 16, 2025

Why Analysts See the ARS Pharmaceuticals Story Shifting Amid Changing Growth and Market Risks - Yahoo Finance

Nov 16, 2025

Nov 16, 2025

Applying chart zones and confluence areas to ARS Pharmaceuticals Inc.Quarterly Portfolio Report & Weekly Setup with ROI Potential - newser.com

Nov 16, 2025

Nov 16, 2025

Why ARS Pharmaceuticals Inc. stock could outperform in 2025Dollar Strength & Risk Managed Investment Strategies - newser.com

Nov 16, 2025

Nov 16, 2025

Why ARS Pharmaceuticals Inc. stock could see breakout soonPortfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

ARS Pharmaceuticals targets renewed growth in 2026 as neffy adoption accelerates and new global launches begin - MSN

Nov 16, 2025

Nov 16, 2025

Insider Selling: ARS Pharmaceuticals (NASDAQ:SPRY) Insider Sells 166,380 Shares of Stock - MarketBeat

Nov 16, 2025

Nov 16, 2025

Multi factor analysis applied to ARS Pharmaceuticals Inc.2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com

Nov 16, 2025

Nov 15, 2025

Will ARS Pharmaceuticals Inc. rebound enough to break evenJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com

Nov 15, 2025